Synergy Spine Solutions announced that its Synergy Disc has been used successfully in 100 cervical disc replacement surgeries in the United States following FDA premarket approval earlier this year.
The milestone reflects widespread surgeon adoption of the Synergy Disc, reported to be the first and only artificial cervical disc designed to intentionally preserve motion while improving anatomic alignment. The device features a 6-degree lordotic core to restore the spine’s natural curve and is made from a nickel-free titanium alloy, helping reduce a potential barrier for patients with nickel sensitivities or allergies.
Across the 100 procedures in the U.S., surgeons voluntarily selected the 6-degree lordotic core option in 98% of cases. This strong surgeon preference reinforces the clinical importance of restoring alignment in addition to preserving motion. Earlier this year, the Synergy Disc received FDA Premarket Approval for 1-level indications at C3-C7.
“Reaching 100 U.S. cases within 100 days of our first commercial procedure reflects the strong early adoption of our technology and the growing demand among surgeons for cervical disc replacement solutions designed to support both motion and alignment,” said Troy Wahlenmaier, Chief Commercial Officer of Synergy Spine Solutions. “Our focus remains on scaling thoughtfully – supporting surgeons throughout the rollout while expanding access to a technology backed by more than a decade of international clinical experience.”
Synergy Spine Solutions announced that its Synergy Disc has been used successfully in 100 cervical disc replacement surgeries in the United States following FDA premarket approval earlier this year.
The milestone reflects widespread surgeon adoption of the Synergy Disc, reported to be the first and only artificial cervical disc designed to...
Synergy Spine Solutions announced that its Synergy Disc has been used successfully in 100 cervical disc replacement surgeries in the United States following FDA premarket approval earlier this year.
The milestone reflects widespread surgeon adoption of the Synergy Disc, reported to be the first and only artificial cervical disc designed to intentionally preserve motion while improving anatomic alignment. The device features a 6-degree lordotic core to restore the spine’s natural curve and is made from a nickel-free titanium alloy, helping reduce a potential barrier for patients with nickel sensitivities or allergies.
Across the 100 procedures in the U.S., surgeons voluntarily selected the 6-degree lordotic core option in 98% of cases. This strong surgeon preference reinforces the clinical importance of restoring alignment in addition to preserving motion. Earlier this year, the Synergy Disc received FDA Premarket Approval for 1-level indications at C3-C7.
“Reaching 100 U.S. cases within 100 days of our first commercial procedure reflects the strong early adoption of our technology and the growing demand among surgeons for cervical disc replacement solutions designed to support both motion and alignment,” said Troy Wahlenmaier, Chief Commercial Officer of Synergy Spine Solutions. “Our focus remains on scaling thoughtfully – supporting surgeons throughout the rollout while expanding access to a technology backed by more than a decade of international clinical experience.”
Copy to clipboard 
